To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC11204 | CCR6 inhibitor 35 |
CCR6 inhibitor 35 is a potent and selective CCR6 inhibitor with IC50 of 6.0 nM (hCCR6).
More description
|
|
| DC11975 | AZ 10397767 |
AZ10397767 is a potent, selective CXCR2 inhibitor that inhibits CXCL8 binding to CXCR2 with pIC50 of 9.0.
More description
|
|
| DC11147 | AZ084 |
AZ084 (AZ-084) is a potent, selective, allosteric, orally available CCR8 antagonist with Ki of 0.9 nM.
More description
|
|
| DC11685 | CCX-777 |
A small-molecule partial agonist of CXCR7 (ACKR3)..
More description
|
|
| DC11687 | (S)-CCX-777 |
A small-molecule partial agonist of CXCR7 (ACKR3)..
More description
|
|
| DC11686 | (R)-CCX-777 |
A small-molecule partial agonist of CXCR7 (ACKR3)..
More description
|
|
| DC11698 | α-NETA |
A small molecule CMKLR1 antagonist that inhibits chemerin-stimulated β-arrestin2 association with CMKLR1 (EC50=9.7 nM).
More description
|
|
| DC11977 | SX-517 |
A potent, specific, noncompetitive dual CXCR1 and CXCR2 antagonist with IC50 of 38 nM (vs. CXCL1) and 36 nM (vs. CXCL8), respectively.
More description
|
|
| DC11983 | CX797 |
A potent, specfic CXCR2 antagonist that inhibits IL8 down-regulation of forskolin-induced cAMP with IC50 of 7.79 uM.
More description
|
|
| DC11746 | JNJ-27141491 |
A potent, selective, noncompetitive, orally active CCR2 antagonist with IC50 of 172 nM.
More description
|
|
| DC11744 | CCR2-RA-[R] |
A potent, selective, allosteric CCR2 antagonist with IC50 of 103 nM..
More description
|
|
| DC11745 | BMS-22 |
A potent, selective, allosteric CCR2 antagonist with binding IC50 of 5.1 nM.
More description
|
|
| DC11700 | Chalcone 4 hydrate |
A potent, selective inhibitor of CXCL12 binding to CXCR4 and CXCR7 with IC50 of 200 nM.
More description
|
|
| DC11979 | SB 332235 |
A potent, selective and competitive CXCR2 inhibitor that selectively inhibits CXCR2-mediated recruitment of β-arrestin-2 with pKi of 8.92.
More description
|
|
| DC11976 | SX-576 |
A potent, equipotent CXCR1 and CXCR2 antagonist with IC50 of 31 nM and 21 nM, respectively.
More description
|
|
| DC11699 | VUF11403 |
A potent CXCR7 (ACKR3) agonist..
More description
|
|
| DC11743 | BMS-681 |
A potent and orally bioavailable dual antagonist of CCR2 and CCR5 with binding IC50 of 0.7 nM and 2.4 nM, respectively.
More description
|
|
| DC11981 | CX4152 |
A novel potent, selective CXCR2 inhibitor with IC50 of 7.6 nM.
More description
|
|
| DC11982 | CX815 |
A novel potent, selective CXCR2 inhibitor with IC50 of 0.4 nM.
More description
|
|
